The present invention provides compounds of Formula (I):
##STR1##
wherein R1, R2, R3, R4, R5,
and R6, have any of the values defined in the specification, as well
as pharmaceutical compositions comprising the compounds. The invention also provides
therapeutic methods as well as processes and intermediates useful for preparing
compounds of Formula (I). The compounds are 5-HT ligands and are useful for treating
diseases wherein modulation of 5-HT2C activity is desired.
